Company Filing History:
1 out of 1 
1 out of 1 Years Active: 2025
Title: Innovations of Lianwu Deng in Multi-Target Kinase Inhibitors
Introduction
Lianwu Deng, an innovative inventor based in Guangdong, China, has made significant contributions to the pharmaceutical field. With one patent to his name, he is recognized for his work on multi-target kinase inhibitors, which have the potential to revolutionize treatments for various cancers and other diseases.
Latest Patents
Lianwu Deng holds a notable patent titled "Multi-target kinase inhibitor, pharmaceutical composition, and preparation method for multi-target kinase inhibitor and use thereof." This invention describes a multi-target kinase inhibitor represented by a specific formula, which effectively inhibits enzymatic activities of notable kinases such as RET, VEGFR3, and PDGFRA. The versatility of this inhibitor allows it to treat various cancers, including those affecting the breast, respiratory tract, brain, reproductive organs, digestive tract, urinary tract, eyes, liver, skin, head and neck, as well as distant metastatic cancers, lymphoma, sarcoma, and leukemia. The pharmaceutical composition formulated includes the multi-target kinase inhibitor, constituting 1-50 wt % of the overall composition.
Career Highlights
Throughout his career, Lianwu Deng has worked with prominent companies in the biotechnology sector, including Guangzhou Liushun Biotechnology Co., Ltd. and Beijing Beikehuaxia Biomedical Technology Co., Ltd. His expertise in the development of intricate pharmaceutical compositions has positioned him as a key player in the fight against cancer and other diseases.
Collaborations
During his professional journey, Lianwu Deng has collaborated with talented coworkers such as Bing Liu and Jingsi Dai. These collaborations reflect a commitment to advancing research and technology in biomedicine.
Conclusion
Lianwu Deng continues to pave the way for innovations in multi-target kinase inhibitors, showcasing the impact of his work on the treatment of cancers and various diseases. His contributions to the pharmaceutical landscape exemplify the significance of inventive solutions in addressing complex health challenges.